Movement disorders in women: A review

Movement Disorders

Volumn 29, Issue 2, 2014, Pages 177-183

  Rabin, Marcie L ^a   Stevens Haas, Claire ^a   Havrilla, Emilyrose ^a   Devi, Tanvi ^a   Kurlan, Roger ^a  

^a Overlook Medical Center   (United States)

Author keywords

Gender; Movement disorders; Women

Indexed keywords

GENDER; MOVEMENT DISORDERS; WOMEN;

DATABASES, FACTUAL; FEMALE; HUMANS; MALE; MOVEMENT DISORDERS; PREGNANCY; PREGNANCY COMPLICATIONS; WOMEN'S HEALTH;

EID: 84894226826     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.25723     Document Type: Review

References (72)

1. Committee on Understanding the Biology of Sex and Gender Differences, Board on Health Sciences Policy, Institute of Medicine. Executive summary. In: Wizemann TM, Pardue M-L, editors. Exploring the Biological Contributions to Human Health: Does Sex Matter? Washington, DC: National Academy Press; 2001:1-8.
2. Moore KL, Boscardin WJ, Steinman MA, Schwartz JB. Age and sex variation in prevalence of chronic medical conditions in older residents of US nursing homes. J Am Geiatr Soc 2012;60:756-764.
3. Baldereschi M, Di Carlo A, Rocca WA, et al. Parkinson's disease and parkinsonism in a longitudinal study: two-fold higher incidence in men. ILSA Working Group. Italian Longitudinal Study on Aging. Neurology 2000;55:1358-1363.
4. Taylor KS, Cook JA, Counsell CE. Heterogeneity in male to female risk for Parkinson's disease. J Neurol Neurosurg Psychiatry 2007;78:905-906.
5. Van Den Eeden SK, Tanner CM, Bernstein AL, Fross RD, Leimpeter A, Bloch DA, Nelson LM. Incidence of Parkinson's disease: variation by age, gender, and race/ethnicity. Am J Epidemiol 2003;157:1015-1022.
6. Alves G, Muller B, Herlofson K, et al. Incidence of Parkinson's disease in Norway: the Norwegian ParkWest study. J Neurol Neurosurg Psychiatry 2009;80:851-857.
7. Haaxma CA, Bloem BR, Borm GF, et al. Gender differences in Parkinson's disease. J Neurol Neurosurg Psychiatry 2007;78:819-824.
8. Payami H, Larsen K, Bernard S, Nutt J. Increased risk of Parkinson's disease in parents and siblings of patients. Ann Neurol 1994;36:659-661.
9. Ragonese P, D'Amelio M, Salemi G, et al. Risk of Parkinson disease in women: effect of reproductive characteristics. Neurology 2004;62:2010-2014.
10. Popat RA, Van Den Eeden SK, Tanner CM, et al. Effect of reproductive factors and postmenopausal hormone use on the risk of Parkinson disease. Neurology 2005;65:383-390.
11. Benedetti MD, Maraganore DM, Bower JH, et al. Hysterectomy, menopause, and estrogen use preceding Parkinson's disease: an exploratory case-control study. Mov Disord 2001;16:830-837.
12. Rocca WA, Bower JH, Maraganore DM, Ahlskog, JE, Grossardt BR, de Andrade M, Melton LJ 3rd. Increased risk of parkinsonism in women who underwent oophorectomy before menopause. Neurology 2008;70:200-209.
13. Savica R, Grossardt BR, Bower JH, Ahlskog JE, Rocca WA. Risk factors for Parkinson's disease may differ in men and women: an exploratory study. Horm Behav 2013;63:308-314.
14. Lavalaye J, Booij J, Reneman L, Habraken JBA, van Royen EA. Effect of age and gender on dopamine transporter imaging with [123I]FP-CIT SPET in healthy volunteers. Eur J Nucl Med 2000;27:867-869.
15. Kaplan PW. Neurologic Disease in Women. New York, NY: Demos Medical Publishing Inc.; 2006.
16. Shulman LM. Gender differences in Parkinson's disease. Gender Med 2007;4:8-18.
17. Miller IN, Cronin-Golomb A. Gender differences in Parkinson's disease: clinical characteristics and cognition. Mov Disord 2010;25:2695-2703.
18. Lyons KE, Hubble JP, Troster AI, Pahwa R, Koller WC. Gender differences in Parkinson's disease. Clin Neuropharmacol 1998;21:118-121.
19. Zappia M, Annesi G, Nicoletti G, et al. Sex differences in clinical and genetic determinants of levodopa peak-dose dyskinesias in parkinson disease: an exploratory study. Arch Neurol 2005;62:601-605.
20. Joutsa J, Martikainen K, Vahlberg T, Kaasinen V. Effects of dopamine agonist dose and gender on the prognosis of impulse control disorders in Parkinson's disease. Parkinsonism Relat Disord 2012;18:1079-1083.
21. Bjornara KA, Dietrichs E, Toft M. REM sleep behavior disorder in Parkinson's disease-is there a gender difference? Parkinsonism Relat Disord 2013;19:120-122.
22. Fernandez HH, Lapane KL, Ott BR, Friedman JH. Gender differences in the frequency and treatment of behavior problems in Parkinson's disease. Mov Disord 2000;15:490-496.
23. Schneider JL, Fink HA, Ewing SK, Ensrud KE, Cummings SR;Study of Osteoporotic Fractures (SOF) Research Group. The association of Parkinson's disease with bone mineral density and fracture in older women. Osteoporos Int 2008;19:1093-1097.
24. Hariz GM, Hariz MI. Gender distribution in surgery for Parkinson's disease. Parkinsonism Relat Disord 2000;6:155-157.
25. Hariz GM, Lindberg M, Hariz MI, Bergenheim AT. Gender differences in disability and health-related quality of life in patients with Parkinson's disease treated with stereotactic surgery. Acta Neurol Scand 2003;108:28-37.
26. Accolla E, Caputo E, Cogiamanian F, et al. Gender differences in patients with Parkinson's disease treated with subthalamic deep brain stimulation. Mov Disord 2007;22:1150-1156.
27. Olanow CW, Kieburtz K, Rascol O, et al. for the STRIDE-PD Investigators. Factors predictive of the development of levodopa-induced dyskinesia and wearing-off in Parkinson's disease. Mov Disord 2013;28:1064-1071.
28. Kompoliti K, Comella CL, Jaglin JA, Leurgans S, Raman R, Goetz CG. Menstrual-related changes in motoric function in women with Parkinson's disease. Neurology 2000;55:1572-1575.
29. Tolson D, Fleming V, Schartau E. Coping with menstruation: understanding the needs of women with Parkinson's disease. J Adv Nurs 2002;40:513-521.
30. Bordelon YM, Smith M. Movement disorders in pregnancy. Semin Neurol 2007;27:467-475.
31. Shulman LM, Minagar A, Weiner WJ. The effect of pregnancy in Parkinson's disease. Mov Disord 2000;15:132-135.
32. Golbe L. Pregnancy and movement disorders. Neurol Clin 1994;12:497-508.
33. Hagell P, Odin P, Vinge E. Pregnancy in Parkinson's disease: a review of the literature and a case report. Mov Disord 1998;13:34-38.
34. Calne SM, Kumar A. Young onset Parkinson's disease. Practical management of medical issues. Parkinsonism Relat Disord 2008;14:133-142.
35. Morissette M, Di Paolo T. Sex and estrous cycle variations of rat striatal dopamine uptake sites. Neuroendocrinology 1993;58:16-22.
36. Rodriguez-Perez AI, Valenzuela R, Villar-Cheda B, Guerra MJ, Lanciego JL, Labandeira-Garcia JL. Estrogen and angiotensin interaction in the substantia nigra. Relevance to postmenopausal Parkinson's disease. Exp Neurol 2010;224:517-526.
37. Shulman LM. Is there a connection between estrogen and Parkinson's disease? Parkinsonism Relat Disord 2002;8:289-295.
38. World Health Organization. Pharmacovigilance focus: estrogen therapy and symptoms of parkinsonism: a review using WHO's ADR data base. In: WHO Drug Information. Geneva, Switzerland: World Health Organization; 2007:270.
39. Saunders-Pullman R, Gordon-Elliott J, Parides M, Fahn S, Saunders HR, Bressman S. The effect of estrogen replacement on early Parkinson's disease. Neurology 1999;52:1417-1421.
40. Currie LJ, Harrison MB, Trugman JM, Bennett JP, Wooten GF. Postmenopausal estrogen use affects risk for parkinson disease. Arch Neurol 2004;61:886-888.
41. Shulman LM;the Parkinson Study Group. The POETRY study: the safety, tolerability and efficacy of estrogen replacement therapy in post-menopausal women with Parkinson's disease. Mov Disord 2006;21:1545-1545.
42. Tsang KL, Ho SL, Lo SK. Estrogen improves motor disability in parkinsonian postmenopausal women with motor fluctuations. Neurology 2000;54:2292-2298.
43. Lewin AB, Murphy TK, Storch EA, et al. A phenomenological investigation of women with Tourette or other chronic tic disorders. Compr Psychiatry 2012;53:525-534.
44. Jankovic J. Tourette's syndrome. N Engl J Med 2001;345:1184-1192.
45. Kurlan R. Tourette's syndrome. N Engl J Med 2010;363:2332-2338.
46. Schwabe MJ, Konkol RJ. Menstrual cycle-related fluctuations of tics in Tourette syndrome. Pediatr Neurol 1992;8:43-46.
47. Pauls DL, Leckman JF. The inheritance of Gilles de la Tourette's syndrome and associated behaviors: evidence for autosomal dominant transmission. N Engl J Med 1986;315:993-997.
48. Lewin AB, Storch EA, Conelea CA, et al. The roles of anxiety and depression in connecting tic severity and functional impairment. J Anxiety Disord 2011;25:164-168.
49. Robertson MM. The Gilles de la Tourette syndrome: the current status. Arch Dis Child Educ Pradt Ed 2012;97:166-175.
50. Lichter DG, Jackson LA, Schachter M. Clinical evidence of genomic imprinting in Tourette's syndrome. Neurology 1995;45:924-928.
51. Kurlan R. The pathogenesis of Tourette's syndrome: a possible role for hormonal and excitatory neurotransmitter influences in brain development. Arch Neurol 1992;49:874-876.
52. Peterson BS, Leckman JF, Scahill L, et al. Steroid hormones and CNS sexual dimorphisms modulate symptom expression in Tourette's syndrome. Psychoneuroendocrinology 1992;17:553-563.
53. Peterson BS, Leckman JF, Scahill L, et al. Steroid hormones and Tourette's syndrome: early experience with antiandrogen therapy. J Clin Psychopharmacol 1994;14:131-135.
54. Peterson BS, Zhang H, Anderson GM, Leckman JF. A double-blind, placebo-controlled, crossover trial of an antiandrogen in the treatment of Tourette's syndrome. J Clin Psychopharmacol 1998;18:324-331.
55. Khalifa N, von Knorring AL. Tourette syndrome and other tic disorders in a total population of children: clinical assessment and background. Acta Paediatr 2005;94:1608-1614.
56. Motlagh M, Katsovich L, Thompson N, et al. Severe psychosocial stress and heavy cigarette smoking during pregnancy: an examination of the pre- and perinatal risk factors associated with ADHD and Tourette syndrome. Eur Child Adolesc Psychiatry 2010;19:755-764.
57. Matthews C, Bimson B, Lowe TL, et al. Association between maternal smoking and increased symptom severity in Tourette's syndrome. Am J Psychiatry 2006;163:1066-1073.
58. Sener EB, Kocamanoglu S, Ustun E, Tur A. Anesthetic management for cesarean delivery in a woman with Gilles de la Tourette's syndrome. Int J Obstet Anesth 2006;15:163-165.
59. Riddoch D, Jefferson M, Bickerstaff ER. Chorea and the oral contraceptives. Br Med J 1971;4:217-218.
60. Cardoso F. Chorea gravidarum. Arch Neurol 2002;59:868-870.
61. Maia DP, Fonseca PG, Camargos ST, Pfannes C, Cunningham MC, Cardoso F. Pregnancy in patients with Sydenham's chorea. Parkinsonism Relat Disord 2012;18:458-461.
62. Pulsinelli WA, Hamill RW. Chorea complicating oral contraceptive therapy. Case report and review of the literature. Am J Med 1978;65:557-559.
63. Farrer L, Cupples A, Kiely DK, Conneally PM, Myers RH. Inverse relationship between age at onset of Huntington disease and paternal age suggests involvement of genetic imprinting. Am J Hum Genet 1992;50:528-535.
64. Soland VL, Bhatia KP, Marsden CD. Sex prevalence of focal dystonias. J Neurol Neurosurg Psychiatry 1996;60:204-205.
65. Gwinn-Hardy KA, Adler CH, Weaver AL, Fish NM, Newman SJ. Effect of hormone variations and other factors on symptom severity in women with dystonia. Mayo Clin Proc 2000;75:235-240.
66. Paluzzi A, Bain PG, Liu X, Yianni J, Kumarendran K, Aziz TZ. Pregnancy in dystonic women with in situ deep brain stimulators. Mov Disord 2006;21:695-698.
67. Rogers JD, Fahn S. Movement disorders and pregnancy. Adv Neurol 1994;64:163-178.
68. Ohayon MM, Rother T. Prevalence of restless leg syndrome and periodic limb movement disorder in the general population. J Psychosom Res 2002;53:547-554.
69. Budhiraja P, Budhiraja R, Goodwin JL, et al. Incidence of restless legs syndrome and its correlates. J Clin Sleep Med 2012;8:119-124.
70. Aul EA, Davis BJ, Rodnitzky RL. The importance of formal serum iron studies in the assessment of restless legs syndrome. Neurology 1998;51:912-912.
71. Manconi M, Ulfberg J, Berger K, et al. When gender matters: restless legs syndrome. Report of the "RLS and Woman" workshop endorsed by the European RLS Study Group. Sleep Med Rev 2012;16:297-307.
72. Litwin T, Gromadzka G, Czlonkowska A. Gender differences in Wilson's disease. J Neurol Sci. 2012;312(1-2):31-35.